These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21329900)

  • 1. Measuring myocardial scar by CMR.
    Kwong RY; Farzaneh-Far A
    JACC Cardiovasc Imaging; 2011 Feb; 4(2):157-60. PubMed ID: 21329900
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance.
    Flett AS; Hasleton J; Cook C; Hausenloy D; Quarta G; Ariti C; Muthurangu V; Moon JC
    JACC Cardiovasc Imaging; 2011 Feb; 4(2):150-6. PubMed ID: 21329899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR.
    Moravsky G; Ofek E; Rakowski H; Butany J; Williams L; Ralph-Edwards A; Wintersperger BJ; Crean A
    JACC Cardiovasc Imaging; 2013 May; 6(5):587-96. PubMed ID: 23582356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CMR-based identification of critical isthmus sites of ischemic and nonischemic ventricular tachycardia.
    Piers SR; Tao Q; de Riva Silva M; Siebelink HM; Schalij MJ; van der Geest RJ; Zeppenfeld K
    JACC Cardiovasc Imaging; 2014 Aug; 7(8):774-84. PubMed ID: 25051947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial fibrosis evaluated by Look-Locker and late gadolinium enhancement magnetic resonance imaging in apical hypertrophic cardiomyopathy: association with ventricular tachyarrhythmia and risk factors.
    Amano Y; Takeda M; Tachi M; Kitamura M; Kumita S
    J Magn Reson Imaging; 2014 Aug; 40(2):407-12. PubMed ID: 24924216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated Cardiac MR Scar Quantification in Hypertrophic Cardiomyopathy Using Deep Convolutional Neural Networks.
    Fahmy AS; Rausch J; Neisius U; Chan RH; Maron MS; Appelbaum E; Menze B; Nezafat R
    JACC Cardiovasc Imaging; 2018 Dec; 11(12):1917-1918. PubMed ID: 30121270
    [No Abstract]   [Full Text] [Related]  

  • 7. How should infarct size be measured on LGE sequences? A call for a change in the guidelines.
    Nacif MS; Chugh AR; Lima JA; Bluemke DA
    JACC Cardiovasc Imaging; 2011 Nov; 4(11):1223; author reply 1224. PubMed ID: 22093276
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiac magnetic resonance image-based classification of the risk of arrhythmias in post-myocardial infarction patients.
    Kotu LP; Engan K; Borhani R; Katsaggelos AK; Ørn S; Woie L; Eftestøl T
    Artif Intell Med; 2015 Jul; 64(3):205-15. PubMed ID: 26239472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac computed tomographic imaging to evaluate myocardial scarring/fibrosis in patients with hypertrophic cardiomyopathy: a comparison with cardiac magnetic resonance imaging.
    Berliner JI; Kino A; Carr JC; Bonow RO; Choudhury L
    Int J Cardiovasc Imaging; 2013 Jan; 29(1):191-7. PubMed ID: 22527259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging.
    Gao P; Yee R; Gula L; Krahn AD; Skanes A; Leong-Sit P; Klein GJ; Stirrat J; Fine N; Pallaveshi L; Wisenberg G; Thompson TR; Prato F; Drangova M; White JA
    Circ Cardiovasc Imaging; 2012 Jul; 5(4):448-56. PubMed ID: 22572740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of imaging in ablation therapy of ventricular arrhythmias. Focus on cardiac magnetic resonance imaging.
    Yokokawa M; Mueller G; Bogun F
    Circ J; 2012; 76(6):1292-8. PubMed ID: 22739077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial scar as arrhythmia risk in patients with hypertrophic cardiomyopathy.
    Amado LC; Lima JA
    Curr Opin Cardiol; 2010 May; 25(3):276-81. PubMed ID: 20224393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing a novel automatic 3D method for LGE-CMR quantification of scar size with established methods.
    Woie L; Måløy F; Eftestøl T; Engan K; Edvardsen T; Kvaløy JT; Ørn S
    Int J Cardiovasc Imaging; 2014 Feb; 30(2):339-47. PubMed ID: 24249515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of myocardial scar characterization to predict ventricular arrhythmia in cardiac resynchronization therapy.
    Fernández-Armenta J; Berruezo A; Mont L; Sitges M; Andreu D; Silva E; Ortiz-Pérez JT; Tolosana JM; de Caralt TM; Perea RJ; Calvo N; Trucco E; Borràs R; Matas M; Brugada J
    Europace; 2012 Nov; 14(11):1578-86. PubMed ID: 22562658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-infarct myocardial scar imaging in patients with ICD.
    le Polain de Waroux JB; Montant P; Scavee C; Gerber BL; Vanoverschelde JL
    Eur Heart J Cardiovasc Imaging; 2013 Jan; 14(1):89. PubMed ID: 22898713
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessment of myocardial infarction and postinfarction scar remodeling with an elastin-specific magnetic resonance agent.
    Wildgruber M; Bielicki I; Aichler M; Kosanke K; Feuchtinger A; Settles M; Onthank DC; Cesati RR; Robinson SP; Huber AM; Rummeny EJ; Walch AK; Botnar RM
    Circ Cardiovasc Imaging; 2014 Mar; 7(2):321-9. PubMed ID: 24363356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy.
    Bruder O; Wagner A; Jensen CJ; Schneider S; Ong P; Kispert EM; Nassenstein K; Schlosser T; Sabin GV; Sechtem U; Mahrholdt H
    J Am Coll Cardiol; 2010 Sep; 56(11):875-87. PubMed ID: 20667520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [What is late gadolinium enhancement in hypertrophic cardiomyopathy?].
    Moon JC
    Rev Esp Cardiol; 2007 Jan; 60(1):1-4. PubMed ID: 17288947
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessment of nonischemic fibrosis in hypertrophic cardiomyopathy: comparison of gadopentetate dimeglumine and gadobenate dimeglumine for enhanced cardiovascular magnetic resonance imaging.
    Rudolph A; von Knobelsdorff-Brenkenhoff F; Wassmuth R; Prothmann M; Utz W; Schulz-Menger J
    J Magn Reson Imaging; 2014 May; 39(5):1153-60. PubMed ID: 24151119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of recently infarcted myocardium from chronic myocardial scar: the value of contrast-enhanced SSFP-based cine MR imaging.
    Kim KA; Seo JB; Do KH; Heo JN; Lee YK; Song JW; Lee JS; Song KS; Lim TH
    Korean J Radiol; 2006; 7(1):14-9. PubMed ID: 16549951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.